In a report released today, Lance Vitanza from TD Cowen reiterated a Buy rating on Compass Diversified Holdings (CODI – Research Report), with ...

Gautam Khanna, analyst at TD Cowen, shares his outlook for Boeing and says it will take "a number of years" before the ...

TD Cowen downgraded Paycor HCM (PYCR) to Hold from Buy with a price target of $22.50, up from $22, following the takeover offer from Paychex ...

Pembina Pipeline (NYSE:PBA) +0.5% in Wednesday's trading as analysts at TD Cowen call the stock its top pick for Canadian ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Meta’s Instagram and Google’s YouTube are getting ready to welcome TikTok users, as the Supreme Court upheld a law that ...

Investing.com -- TD Cowen initiated coverage of ConocoPhillips (NYSE: COP) with a "Buy" rating and a $125 price target, ...

With a finite number of carriers in most regions, the LTL industry is much more disciplined on pricing than the highly ...

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...

TD Cowen initiated coverage of Centessa (CNTA) with a Buy rating and no price target The firm says the company’s ORX750 has a “best in class profile as a transformative therapy” in excessive ...

SAP stock upgraded to Buy by TD Cowen, citing rise in ERP priority and AI driving cloud migrations. Read more here.

TD Cowen analyst Tyler Van Buren initiated coverage of CG Oncology (CGON) with a Buy rating and no price target The firm says cretostimogene is differentiated by its “superior” efficacy and ...